Mostrar el registro sencillo del ítem
dc.contributor.author | Hernández, W. | |
dc.contributor.author | Carrasco, F. | |
dc.contributor.author | Vaisberg Wollach, Abraham Jaime | |
dc.contributor.author | Spodine, E. | |
dc.contributor.author | Icker, M. | |
dc.contributor.author | Krautscheid, H. | |
dc.contributor.author | Beyer, L. | |
dc.contributor.author | Tamariz-Angeles, C. | |
dc.contributor.author | Olivera-Gonzales, P. | |
dc.date.accessioned | 2023-10-12T15:30:07Z | |
dc.date.available | 2023-10-12T15:30:07Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/14275 | |
dc.description.abstract | Ten new thiosemicarbazone derivatives, furan-2-carbaldehyde thiosemicarbazone (1), 3-methyl-furan-2-carbaldehyde thiosemicarbazone (2), 5-hydroxymethyl-furan-2-carbaldehyde thiosemicarbazone (3), 5-trifluoromethyl-furan-2-carbaldehyde thiosemicarbazone (4), 5-nitro-furan-2-carbaldehyde thiosemicarbazone (5), 5-phenyl-furan-2-carbaldehyde thiosemicarbazone (6), 5-(2-fluorophenyl)-furan-2-carbaldehyde thiosemicarbazone (7), 5-(4-methoxyphenyl)-furan-2-carbaldehyde thiosemicarbazone (8), 5-(1-naphthyl)-furan-2-carbaldehyde thiosemicarbazone (9), and 5-(1H-Pyrazol-5-yl)-furan-2-carbaldehyde thiosemicarbazone (10) were synthesized by condensing thiosemicarbazide with the respective furan-2-carbaldehyde in methanol. The prepared compounds were characterized by spectroscopic studies (FT-IR and NMR) and electrospray mass spectrometry. The molecular structures of 2, 6, 7, and 8 have also been determined by X-ray crystallography. Compounds 2, 6, and 7 crystallize in the E conformation about the N1-C6, N1-C11, and N1-C11 bonds, respectively, while 8 adopts the Z conformation about the N1-C12 bond with the presence of an intramolecular N2-H.O2 hydrogen bond. All prepared thiosemicarbazone derivatives were evaluated for their in vitro antibacterial, antifungal, and antitumor activities against Staphylococcus aureus strains, Candida albicans/Candida tropicalis fungi, and seven human tumor cell lines (HuTu80, H460, DU145, M-14, HT-29, MCF-7, and LNCaP), respectively. The antioxidant activity was also studied by the DPPH assay. Compound 5 exhibited significant antibacterial activity against Staphylococcus aureus ATCC700699 (MIC = 1 μg/mL) compared to the nitrofurantoin and gentamicin reference drugs (MIC = 1-25 and 10->100 μg/mL, respectively). Compound 4 was ten times less active than amphotericin B (MIC = 5 μg/mL) against Candida albicans (ATCC90028 and ATCC10231), while 1 exhibited a moderate effect of scavenging of DPPH radical (IC50 = 40.9 μg/mL) in comparison to ascorbic acid reference compound (IC50 = 22.0 μg/mL). Among all the studied thiosemicarbazones, 5 showed a higher cytotoxic activity (IC50 = 13.36-27.73 μΜ) in relation to the other tested compounds (IC50 = 34.84 - >372.34 μΜ) against all tested cell lines, except the LNCaP cell line, exhibiting its highest antiproliferative activity (IC50 = 13.36 μΜ) on the HuTu80 cell line. Besides, 8 and 9 exhibited high antitumor activity (IC50 = 13.31 and 7.69 μΜ, respectively) against the LNCaP cells. | en_US |
dc.language.iso | eng | |
dc.publisher | Hindawi | |
dc.relation.ispartofseries | Journal of Chemistry | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Thiosemicarbazone | en_US |
dc.subject | Furan-2-Carbaldehyde | en_US |
dc.subject | Crystal Structures | en_US |
dc.subject | Antibacterial | en_US |
dc.subject | Antifungal | en_US |
dc.subject | Antioxidant | en_US |
dc.subject | Antitumor | en_US |
dc.subject.mesh | Tiosemicarbazonas | |
dc.subject.mesh | Antibacterianos | |
dc.subject.mesh | Antifúngicos | |
dc.subject.mesh | Antioxidantes | |
dc.subject.mesh | Neoplasias | |
dc.title | Novel Thiosemicarbazone Derivatives from Furan-2-Carbaldehyde: Synthesis, Characterization, Crystal Structures, and Antibacterial, Antifungal, Antioxidant, and Antitumor Activities | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1155/2023/5413236 | |
dc.relation.issn | 2090-9063 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |